Neurology Podcast
Practical, relevant, timely information for neurologists and all clinicians to practice the best possible medicine for our patients.
Subscribe: Libsyn Feed / Apple Podcasts / Google Podcasts / Spotify / Stitcher / RSS
Meet the Contributors of Neurology® Podcast and Neurology Minute®
May 19, 2022 Issue
Neurodegeneration in Pro Football Players: ALS
In the first part of our two-part series on neurodegeneration in professional football players, Dr. Shuvro Roy talks with Dr. Ann McKee about the high incidence and mortality rates of amyotrophic lateral sclerosis (ALS) in NFL athletes. For more information on the VA-BU-CLF Brain Bank at the Boston University CTE Center, including brain donation inquiries, click here.
Disclosures can be found at Neurology.org.
May 17, 2022 Issue
Peripheral Neuropathy and Prolonged COVID
Dr. Derek Stitt talks with Dr. Anne Oaklander about the association of long COVID with incident polyneuropathy affecting the small-fiber axons. Read the full article in Neurology: Neuroimmunology & Neuroinflammation.
Disclosures can be found at Neurology.org.
May 12, 2022 Issue
Cardiac Arrhythmia in Patients with Drug-Resistant Epilepsy
Dr. Halley Alexander talks with Dr. Shóbi Sivathamboo about the incidence of serious cardiac arrhythmias detected by subcutaneous cardiac monitors in patients with chronic drug-resistant epilepsy. Read the full article in Neurology.
Disclosures can be found at Neurology.org.
May 10, 2022 Issue
Neuromodulation Restores Function in Spinal Cord Injury
Dr. Jeff Ratliff talks with Dr. Andreas Rowald about the efficacy of activity-dependent spinal cord neuromodulation, which was shown to rapidly restore trunk and leg motor functions in patients with spinal cord injury after complete paralysis.
Disclosures can be found at Neurology.org.
May 5, 2022 Issue
Prognosis and Treatment of Spinal Cord Sarcoidosis
Dr. Stacey Clardy discusses the prognostic factors and efficacy of immunosuppressive treatments for spinal cord sarcoidosis with Dr. Antoine Gavoille. Read the full article in Neurology.
Disclosures can be found at Neurology.org.
May 3, 2022 Issue
Cost Burden of MS in the US
Dr. Justin Abbatemarco talks with Dr. Bruce Bebo about the estimated economic burden of multiple sclerosis in the US, highlighting direct and indirect cost drivers. Read the full article in Neurology.
Please be sure to check out the National Multiple Sclerosis Society's "MS Navigator" resource, which connects patients with MS and their family members to experts who can help them navigate the challenges of MS, from making workplace accommodation requests to case management assessment.
Disclosures can be found at Neurology.org.
April 28, 2022 Issue
Brain Networks and Cognitive Decline in DBS for Parkinson Disease
Dr. Jeff Ratliff talks with Dr. Michael Fox about the association of connectivity between brain networks and sites of deep brain stimulation (DBS) with DBS-induced cognitive decline in patients with Parkinson disease. Check out the free clinical tool designed to help DBS programmers based on the research discussed in this episode here.
Disclosures can be found at Neurology.org.
April 26, 2022 Issue
Sudden Death and Cardiac Arrhythmia with Lamotrigine
Dr. Halley Alexander talks with Dr. Mark Keezer about the risk of sudden death and cardiac arrhythmia in patients utilizing lamotrigine to treat epilepsy. Read the full article in Neurology.
Disclosures can be found at Neurology.org.
April 21, 2022 Issue
Priorities from the 2022 ADRD Summit with Walter Koroshetz
Dr. Gregg Day talks with Dr. Walter Koroshetz, Director of NINDS, about research recommendations, priorities, and outcomes at the 2022 Alzheimer's Disease-Related Dementias (ADRD) Summit.
Disclosures can be found at Neurology.org.
April 19, 2022 Issue
Amyloid Treatments for Alzheimer Disease
Dr. Jason Crowell talks with Dr. Gregg Day about amyloid-targeting treatments for Alzheimer disease as well as how to navigate conversations about aducanumab with patients.
Disclosures can be found at Neurology.org.
April 14, 2022 Issue
Availability of Lomustine for Glioblastoma Multiforme
Dr. Jeff Ratliff talks with Drs. Howard Colman and Kelly Fritz about the availability of lomustine for the treatment of glioblastoma multiforme (GBM) in light of the drug's recent withdrawal from Medicare Part D coverage.
Disclosures can be found at Neurology.org.
April 12, 2022 Issue
Neurologic Causes of Postpartum Readmission
Dr. Tesha Monteith talks with Dr. Barbara Decker about maternal obstetric complications and non-elective postpartum readmissions in women with prior stroke, migraine, multiple sclerosis, and myasthenia gravis. Read the full article in Neurology.
Disclosures can be found at Neurology.org.
April 7, 2022 Issue
Genetic Testing for White Matter Disorders
Dr. Justin Abbatemarco talks with Dr. Aurora Pujol about diagnosing genetic white matter disorders by singleton whole-exome and whole-genome sequencing using interactome-driven prioritization. Read the full article in Neurology.
Disclosures can be found at Neurology.org.
April 5, 2022 Issue
Patient-Centered Treatment of Migraine with Medication Overuse
Dr. Tesha Monteith talks with Dr. Todd Schwedt about the treatment of chronic migraine with medication overuse through the patient-centered Medication Overuse Treatment Strategy (MOTS) clinical trial. Read the full article in Neurology.
Disclosures can be found at Neurology.org.
April 1, 2022 Issue
April 2022 Neurology Recall: Physician as Patient
The April 2022 replay of past episodes showcases a selection of interviews with fellow neurologists about their personal experiences as patients. This episode features illuminating conversations with Drs. Daniel Drubach, Daniel Gibbs, Ted Burns, and Oliver Sacks, offering our listeners essential lessons and insights into the importance of physician empathy.
Disclosures can be found at Neurology.org.
March 31, 2022 Issue
Spinal Muscular Atrophy
Dr. Gordon Smith talks with Dr. Charlotte Sumner about spinal muscular atrophy, highlighting the historic milestone reached with three medications receiving FDA approval for the treatment of SMA.
Disclosures can be found at Neurology.org.
March 29, 2022 Issue
Neuro-Respiratory Criteria for Death Determination
Dr. Jason Crowell talks with Drs. Ariane Lewis and David Magnus about the need to update the Uniform Declaration of Death Act (UDDA), aligning the legal criteria with the medical standards used to determine death by neurological criteria. Read the full article in Neurology.
Disclosures can be found at Neurology.org.
March 24, 2022 Issue
ARIA Associated with Aducanumab
Dr. Jeff Burns talks with Dr. Lon Schneider about the development of ARIA in the Phase 3 EMERGE and ENGAGE trials that led to the FDA's accelerated approval of aducanumab for the treatment of Alzheimer disease.
Disclosures can be found at Neurology.org.
March 22, 2022 Issue
Cognitive Outcomes in mTBI
Dr. Alex Menze talks with Dr. Raquel Gardner about the development of a clinically-relevant definition of poor cognitive outcome one year after mild traumatic brain injury (mTBI) and whether outcomes can be predicted by baseline clinical variables. Read the full article in Neurology.
Disclosures can be found at Neurology.org.
March 17, 2022 Issue
A Discussion with Dr. Giesser: Ted Burns Humanism Award Winner
This episode features Dr. Stacey Clardy in conversation with the 2022 Ted Burns Humanism in Neurology Award Winner, Dr. Barbara Giesser.
Disclosures can be found at Neurology.org.
March 15, 2022 Issue
CSF Biomarkers in FTD and Alzheimer Disease
Dr. Gregg Day talks with Dr. Niklas Mattsson-Carlgren about the correlation of cerebrospinal fluid biomarkers with autopsy-confirmed Alzheimer disease and frontotemporal lobar degeneration. Read the full article in Neurology.
Disclosures can be found at Neurology.org.
March 10, 2022 Issue
Association of EBV and Multiple Sclerosis
Dr. Shuvro Roy talks with Dr. Alberto Ascherio about the association of Epstein-Barr virus and multiple sclerosis, highlighting his study's stronger evidence for this viral connection.
Disclosures can be found at Neurology.org.
March 8, 2022 Issue
Tic Network Localization and DBS
Dr. Jeff Ratliff talks with Dr. Christos Ganos about the use of brain lesion network mapping to interrogate whether tic disorder-inducing lesions are associated with a common network in the average human brain.
Disclosures can be found at Neurology.org.
March 2, 2022 Issue
March 2022 Neurology Recall: Prognosis and Treatment of Guillain-Barré Syndrome
The March 2022 replay of past episodes showcases a selection of interviews regarding the prognosis and treatment of Guillain-Barré Syndrome. This episode features Drs. Ted Burns, Jeff Ratliff, and Michelle Mauermann in conversation with Dr. Bart Jacobs over the course of a decade, highlighting the progress he and his team have made in treating and predicting outcomes in GBS over time.
March 1, 2022 Issue
Equal Pay For Women Neurologists: Show Us the Money!
Dr. Tesha Monteith talks with Dr. Elizabeth Loder about her editorial on the gender pay gap in academic neurology and its impact on women neurologists as well as the field at large. Read the full article in Neurology.
Disclosures can be found at Neurology.org.
February 24, 2022 Issue
Shared Genetics of Migraine, Stroke, and Cervical Dissection
Dr. Andy Southerland talks with Dr. Daniel Chasman about the shared genetic risk of migraine, stroke, and cervical artery dissection (CeAD), a triad of neurologic disorders with vascular involvement. Read the full article in Neurology: Genetics.
Disclosures can be found at Neurology.org.
February 22, 2022 Issue
Seizure Frequency in Pregnancy
Dr. Halley Alexander discusses whether epilepsy type, seizure location, or antiseizure medications influence seizure frequency during pregnancy and postpartum with Dr. P. Emanuela Voinescu. Read the full article in Neurology.
Disclosures can be found at Neurology.org.
February 17, 2022 Issue
GFAP Autoimmune Syndrome
Dr. Stacey Clardy discusses the clinical, biological, and imaging features—as well as the overall clinical course—of a French cohort of patients with glial fibrillar acidic protein (GFAP) autoantibodies with Dr. Jérôme Honnorat. Read the full article in Neurology.
Disclosures can be found at Neurology.org.
February 15, 2022 Issue
Pharmacy Benefits and Disease-Modifying Therapies
Dr. Justin Abbatemarco talks with Dr. Daniel Hartung about the association between Medicare Part D Plan disease-modifying therapy restrictiveness and adherence and outcomes among people with multiple sclerosis. Read the full article in Neurology.
Disclosures can be found at Neurology.org.
February 10, 2022 Issue
Predicting Outcomes in GBS
Dr. Jeff Ratliff talks with Dr. Bart Jacobs about his study on the validity and region-specificity of the modified Erasmus GBS Outcome Score in predicting the risk of walking inability in patients with Guillain-Barré syndrome. Read the full article in Neurology.
Disclosures can be found at Neurology.org.
February 7, 2022 Issue
A Neurologist’s Personal Experience with DLB
Dr. Stacey Clardy interviews behavioral neurologist Dr. Daniel Drubach about his experience with being diagnosed with Lewy body dementia, highlighting the unique perspective his diagnosis has provided him as a physician and as a patient. Read Dr. Drubach's special article in Continuum: "Twilight and Me: A Soliloquy."
Disclosures can be found at Neurology.org.
February 3, 2022 Issue
Practice Guidelines for Painful Diabetic Neuropathy
Dr. Gordon Smith discusses the AAN Guideline Subcommittee's updated Practice Guideline for the oral and topical treatment of painful diabetic neuropathy with Drs. Raymond Price and Brian Callaghan.
Disclosures can be found at Neurology.org.
February 1, 2022 Issue
February 2022 Neurology Recall: Diagnosing and Treating Immune-Mediated Neuropathies
The February 2022 replay of past episodes showcases a selection of interviews regarding the diagnosis and treatment of immune-mediated neuropathies. This episode features Drs. Stacey Clardy and Ted Burns in conversation with Drs. Luise Appeltshauser, Shahar Shelly, and P. James B. Dyck, offering listeners essential insight into the identification and management of acute autoimmune neuropathy, chronic immune sensory polyradiculopathy, and lumbrosacral radiculoplexus neuropathy.
Disclosures can be found at Neurology.org.
February 1, 2022 Issue
Medicare Coverage of Aducanumab
Dr. Jason Crowell talks with Pulitzer Prize-winning New York Times journalist Pam Belluck about the impact of Medicare’s decision to limit patient access to aducanumab for the treatment of Alzheimer disease, restricting use to individuals in clinical trials.
Disclosures can be found at Neurology.org.
January 27, 2022 Issue
TikTok Tics
Prof. Jon Stone talks with Dr. Tamara Pringsheim and Wall Street Journal columnist Julie Jargon about the increased incidence of teen girls presenting with physical tics and the potential association of exposure to TikTok videos on Tourette syndrome and functional neurologic disorder (FND).
Disclosures can be found at Neurology.org.
January 25, 2022 Issue
Navigating Aducanumab Decisions With Families: An AAN Position Statement
Dr. Jeff Ratliff talks with Dr. Winston Chiong about the new AAN Position Statement on ethical considerations in the use of aducanumab for patients with Alzheimer disease.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this Neurology® Podcast episode and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
January 20, 2022 Issue
Outcomes After Large Vessel Stroke Treated with Tenecteplase Before Thrombectomy
Dr. Dan Ackerman talks with Dr. Gaspard Gerschenfeld about the efficacy, safety, and outcomes of treating large vessel occlusion stroke with tenecteplase before thrombectomy.
Disclosures can be found at Neurology.org.
January 18, 2022 Issue
A Nationwide Cohort Study of Epilepsy-Related Death in Young People
Dr. Halley Alexander discusses the utility of a new systematic classification of epilepsy-related mortality used in a nationwide cohort study of children and young adults in Denmark with Dr. Marius Kløvgaard.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this Neurology® Podcast episode and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
January 13, 2022 Issue
The Amyloid Hypothesis for Alzheimer Disease and Aducanumab
Dr. Jeff Burns discusses the amyloid hypothesis and the challenges clinicians face in navigating discussions on the use of aducanumab for Alzheimer disease with Dr. Erik Musiek.
Disclosures can be found at Neurology.org.
January 11, 2022 Issue
Association Between Location of Epilepsy Surgery and Outcomes
Dr. Halley Alexander talks with Dr. Ezequiel Gleichgerrcht about the association between the anatomical location of surgical lesions and postoperative seizure outcomes in patients with temporal lobe epilepsy.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this Neurology® Podcast episode and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
January 6, 2022 Issue
Antiseizure Medication Withdrawal in Seizure-Free Patients
Dr. Halley Alexander discusses the AAN Guideline Subcommittee’s practice advisory update on antiseizure medication withdrawal in seizure-free patients with Dr. Alison Pack.
Disclosures can be found at Neurology.org.
January 4, 2022 Issue
White Matter MRI Sequelae of Repetitive Head Impacts
Dr. Jeff Ratliff talks with Dr. Michael Alosco about the association between antemortem FLAIR white matter hyperintensities and neuropathology in brain donors exposed to repetitive head impacts.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this Neurology® Podcast episode and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
January 1, 2022 Issue
Concussion and Traumatic Encephalopathy Syndrome (January 2022 Neurology Recall)
The January 2022 replay of past episodes showcases a selection of interviews regarding the diagnosis and effects of traumatic encephalopathy syndrome (TES) and concussions. This episode features Dr. Alex Menze in conversation with Dr. Robert Stern, Dr. Nathan Churchill, and Prof. Antonio Belli, offering listeners a comprehensive understanding of the diagnosis and management of head trauma.
Disclosures can be found at Neurology.org.
December 28, 2021 Issue
70th Anniversary Interviews, Part II
Celebrate the 70th Anniversary of Neurology® with Part II of a series of interviews on the history of the journal featuring editors-in-chief Drs. José Merino, Robert Gross, John Noseworthy, and Robert Griggs as well as Podcast Editors Drs. Ted Burns and Stacey Clardy.
December 21, 2021 Issue
70th Anniversary Interviews, Part I
Celebrate the 70th Anniversary of Neurology® with Part I of a series of interviews on the history of the journal featuring editors-in-chief Drs. José Merino, Robert Gross, John Noseworthy, and Robert Griggs as well as Podcast Editors Drs. Ted Burns and Stacey Clardy.
December 14, 2021 Issue
Effectiveness of Initial Treatment for Infantile Spasms; CNS Hereditary Amyloidosis
In the first part of the podcast, Dr. Halley Alexander discusses the effectiveness of the three first line treatments for infantile spasms with Dr. Zachary Grinspan (00:51). In the second segment, Dr. Gordon Smith talks with Dr. Ricardo Taipa about the clinical manifestations, imaging results, and neuropathological findings associated with CNS involvement in hereditary transthyretin amyloidosis (14:53).
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
December 7, 2021 Issue
COVID Vaccines and Neurology Immunotherapy; Health Disparities in Stroke Interventions
In the first part of the podcast, Dr. Justin Abbatemarco talks with Dr. Avi Nath, Director of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health, about COVID-19 vaccines and neurology immunotherapy (00:56). In the second segment, Dr. Andy Southerland discusses disparities in the utilization of stroke interventions with Dr. Adam de Havenon (18:18).
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
December 1, 2021 Issue
Common Issues in Stroke Management (December 2021 Neurology Recall)
The December 2021 replay of past episodes showcases a selection of interviews regarding the diagnosis and management of stroke. This episode features Dr. Andy Southerland and Will Rondeau in conversation with Drs. Seemant Chaturvedi, Lee Schwamm, Jyri Virta, and Sidsel Hastrup, offering listeners a review across the field of vascular neurology.
Disclosures can be found at Neurology.org.
November 30, 2021 Issue
Small Fiber Neuropathy; Representation of Women in Stroke Clinical Trials
In the first part of the podcast, Dr. Stacey Clardy talks with Dr. Christopher Klein about small fiber neuropathy incidence, prevalence, longitudinal impairments, and disabilities (00:45). In the second segment, Dr. Amy Guzik discusses the representation of women in stroke clinical trials relative to the burden of disease in the population with Dr. Cheryl Carcel (16:12).
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
November 23, 2021 Issue
International Headache Congress 2021; Speech Subtypes in Parkinson Disease
In the first part of the podcast, Dr. Tesha Monteith discusses the International Headache Society and European Headache Federation 2021 joint International Headache Congress with Dr. Patricia Pozo-Rosich (00:45). In the second segment, Dr. Jeff Ratliff talks with Dr. Jan Rusz about identifying speech subtypes in patients with Parkinson disease in response to long-term dopaminergic therapy (8:18).
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
November 16, 2021 Issue
Dopamine Therapy in Early PD; Neurologic Disease Definitions with Immune Checkpoint Inhibitors
In the first part of the podcast, Dr. Jason Crowell discusses the AAN Guideline Subcommittee's practice guideline summary on dopaminergic therapy for motor symptoms in early Parkinson disease with Dr. Anthony Lang (00:45). In the second segment, Dr. Kathryn Nevel talks with Dr. Amanda Guidon about the development of consensus disease definitions for neurologic immune-related adverse events associated with immune checkpoint inhibitors (17:04).
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
November 9, 2021 Issue
Chronic Meningitis; MS Therapies and COVID-19
In the first part of the podcast, Dr. Stacey Clardy discusses the causes, features, evaluation, and treatment of chronic meningeal inflammation or infection with Dr. Allen Aksamit. In the second segment, Dr. Eoin Flanagan talks with Dr. Tomas Kalincik about the associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
November 2, 2021 Issue
Aducanumab: What About the Patient?; Risk of Aneurysm Rupture After Stroke Thrombolysis
In the first part of the podcast, Dr. Gregg Day discusses the importance of patient participation in the decision-making process when considering the use of aducanumab for the treatment of Alzheimer disease with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer’s Disease Center. In the second segment, Dr. Andy Southerland talks with Dr. Jyri Virta about the risk of aneurysm rupture after thrombolysis in patients with acute ischemic stroke and unruptured intracranial aneurysms.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
November 1, 2021 Issue
Lewy Body Dementia (November 2021 Neurology Recall)
The November 2021 replay of past episodes showcases a selection of interviews focused on Lewy body dementia. This episode features interviews with Drs. Elie Matar, Simone Baiardi, and John-Paul Taylor on clinical features and management before closing in conversation with Susan Schneider Williams on her late husband Robin Williams's experience with the disease.
October 26, 2021 Issue
Aducanumab and the Business of Alzheimer Disease; Implicit Light Sensitivity in Migraine
In the first part of the podcast, Dr. Jason Crowell discusses the business of Alzheimer disease and how to approach teaching patients about aducanumab with Dr. Jason Karlawish. In the second segment, Dr. Jennifer Bickel talks with Dr. Eric Kaiser about the contribution of melanopsin and cone signals to light-induced reflexive eye closure in migraine.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
October 19, 2021 Issue
Neurologic Safety of COVID-19 Vaccines; Movement Disorders in Anti-IgLON5 Disease
In the first part of the podcast, Dr. Jason Crowell talks with Dr. Kiran Thakur about the importance of monitoring COVID-19 vaccines for neurologic adverse events and learning from past vaccination programs. In the second segment, Dr. Jeff Ratliff interviews Dr. Carles Gaig about the frequency and types of movement disorders in patients with anti-IgLON5 disease.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
October 12, 2021 Issue
CRISPR-Cas9 for TTR Amyloidosis; Osmotic Demyelination Syndrome
In the first part of the podcast, Dr. Alberto Espay talks with Prof. Julian Gillmore about CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. In the second segment, Dr. Pearce Korb discusses the long-term outcomes of osmotic demyelination syndrome in an updated cohort with Dr. Whitney Fitts.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
October 5, 2021 Issue
Peter Frampton on His Diagnosis of Myositis; Ethical Perspectives on Costly Drugs and Healthcare
In the first part of the podcast, Dr. Ted Burns interviews legendary musician Peter Frampton about his experience with inclusion body myositis and his storied career. For more with Peter Frampton, read the cover story in the October/November 2020 issue of Brain & Life, the AAN’s patient and caregiver magazine. In the second segment, Dr. Gordon Smith talks with Dr. Amy Tsou about the updated AAN Position Statement on ethical concerns raised by high drug costs.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
September 28, 2021 Issue
Ethical Considerations in Dementia Diagnosis; Diagnosis of Mild Cognitive Impairment
In the first part of the podcast, Dr. Jeff Ratliff talks with Dr. Winston Chiong about the updated AAN Position Statement on Ethical Considerations in Dementia Diagnosis and Care. In the second segment, Dr. Gregg Day talks with Dr. Emily Edmonds about differing cognitive, biomarker, and neuropathologic trajectories in subtypes of mild cognitive impairment.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
September 21, 2021 Issue
Effects of Concussions on Midline Brain Structures
Dr. Alex Menze discusses the acute and chronic effects of a history of concussions with Dr. Nathan Churchill.
Disclosures can be found at Neurology.org.
No CME this week.
September 14, 2021 Issue
Comparing MRI Lesions in CNS Demyelinating Disorders; Brain Processing in Patients with Migraine
In the first part of the podcast, Dr. Stacey Clardy talks with Dr. Eoin Flanagan about how MRI T-2 lesion evolution differs across central nervous system demyelinating disorders. In the second segment, Dr. Teshamae Monteith talks with Dr. Gabriela Carvalho about behavioral and neuronal responses to a virtual roller coaster ride in patients with migraine.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
September 7, 2021 Issue
Neuroprosthesis for Anarthria; Clinical Progression of LBD
In the first part of the podcast, Dr. Andy Southerland talks with Dr. Edward Chang about the use of a neuroprosthesis for decoding speech in a paralyzed person with anarthria. In the second segment, Dr. Jeff Ratliff discusses the trajectory and magnitude of the progression of clinical features in Lewy body dementia with Dr. Elie Matar.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
September 1, 2021 Issue
Management of Myasthenia Gravis (September 2021 Neurology Recall)
The September 2021 replay of past episodes showcases a selection of interviews focused on the management of myasthenia gravis. The selected interviews feature Dr. Ted Burns and Dr. Stacey Clardy in conversation with Drs. Gil Wolfe, Joseph Shrager, and Pushpa Narayanaswami before closing with before closing with notes from Dr. Ted Burns on MuSK myasthenia gravis.
August 31, 2021 Issue
Using RT-QuIC to Diagnose DLB; Central Hypersomnia in Multiple Sclerosis
In the first segment, Dr. Matthew Barrett talks with Dr. Simone Baiardi about using real-time quaking-induced conversion (RT-QuIC) to identify patients with Lewy body disease. In the second part of the podcast, Dr. Jeff Ratliff discusses the association of central hypersomnia and fatigue in multiple sclerosis with Dr. Anne-Laure Dubessy.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
August 24, 2021 Issue
Out-of-Pocket Costs for MS Drugs; Part 4 of the Thunderclap Headache Series
In the first segment, Dr. Stacey Clardy talks with Dr. Daniel Hartung about whether closing the Part D coverage gap between 2010-2019 lowered patients’ out-of-pocket costs for multiple sclerosis drugs. In the second part of the podcast, Dr. Teshamae Monteith discusses sex, exercise, and other benign causes of thunderclap headache with Dr. Jonathan Smith in the final part of our four-part series on thunderclap headache.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
August 17, 2021 Issue
Patient Perceptions of FDA Approval; Part 3 of the Thunderclap Headache Series
In the first segment, Dr. Jason Crowell talks with Dr. Paul Ford about patient perceptions of the FDA approval process for disease modifying therapies in people living with multiple sclerosis. In the second part of the podcast, Dr. Teshamae Monteith discusses the management of cerebral aneurysm with Dr. Dileep Yavagal in the third part of our four-part series on thunderclap headache.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
August 10, 2021 Issue
Coma Induction in Status Epilepticus; Part 2 of the Thunderclap Headache Series
In the first segment, Dr. Halley Alexander talks with Dr. Pia De Stefano about the safety and efficacy of artificial coma induction in the treatment of status epilepticus. In the second part of the podcast, Dr. Teshamae Monteith discusses a case presentation of RCVS and clinical management with Dr. Andy Southerland and his patient, Martien Halvorson-Taylor, in the second part of our four-part series on thunderclap headache.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
August 3, 2021 Issue
Psychogenic Nonepileptic Seizures in Children and Adolescents; Part 1 of the Thunderclap Headache Series
In the first segment, Dr. Jon Stone talks with Dr. Anne Sofie Hansen about the spectrum and risk of psychiatric disorders in childhood-onset psychogenic nonepileptic seizures. In the second part of the podcast, Dr. Teshamae Monteith discusses ten causes of thunderclap headache and presentation with Dr. Alexandra Cocores in the first part of our four-part series on thunderclap headache.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
August 1, 2021 Issue
Perspectives on Aducanumab Approval (Neurology Recall August 2021)
This month’s replay of past episodes showcases a selection of interviews concerning the FDA approval of aducanumab for the treatment of Alzheimer disease from clinical, political, and economic perspectives. The selected interviews feature conversations between Dr. Gregg Day and Pam Belluck, Dr. Jeff Burns and Dr. Ron Peterson, Dr. Jason Crowell and Dr. Steve Pearson, and Dr. Jeff Burns and Dr. Daniel Gibbs.
Disclosures can be found at Neurology.org.
July 27, 2021 Issue
Impact of Thymectomy on Myasthenia Gravis Remission
Dr. Stacey Clardy discusses the impact of surgical approaches to thymectomy upon remission rates in myasthenia gravis with Dr. Joseph Shrager.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
July 20, 2021 Issue
Symptoms and Incidence of RCVS; Optimizing Stroke Prevention in Atrial Fibrillation
In the first segment, Will Rondeau discusses the symptoms, incidence, and resource utilization of reversible cerebrovascular vasoconstriction syndrome with Dr. Jessica Magid-Bernstein. In the second part of the podcast, Dr. Andy Southerland discusses the optimization of atrial fibrillation treatment and stroke prevention with Dr. Seemant Chaturvedi.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
July 13, 2021 Issue
Illness in Overseas U.S. Embassies Employees; Afferent Baroreflex Failure
In the first segment, Dr. Alex Menze talks with Dr. Clifford Saper about Havana Syndrome and recent attacks on American diplomats. In the second part of the podcast, Dr. Jeff Ratliff discusses the natural history of afferent baroreflex failure with Dr. Guillaume Lamotte.
Disclosures can be found at Neurology.org.
July 6, 2021 Issue
Evaluations in First Episode Psychosis; Dr. Daniel Gibbs on his Battle with Alzheimer's
In the first segment, Dr. Gregg Day speaks with Dr. Josep Dalmau about NMDAR antibodies in patients with first episode psychosis and the utility of criteria for autoimmune psychosis. In the second part of the podcast, Dr. Jeff Burns talks to neurologist Dr. Daniel Gibbs about his Alzheimer’s disease diagnosis and experience participating in a clinical trial for aducanumab.
Disclosures can be found at Neurology.org.
July 1, 2021 Issue
Management of Neurologic Conditions in Pregnancy (Neurology Recall July 2021)
This month's replay of past episodes showcases a selection of interviews on the impact of pregnancy on various neurologic disorders, featuring Drs. Page Pennell, Paula Emanuela Voinescu, Mary Angela O'Neal, Emma Ciafaloni, Raed Alroughani, Rae Bacharach, Annette Langer-Gould, Nicolas Collongues, and Petra Ijäs.
June 29, 2021 Issue
SPECIAL REPORT: A Discussion With Mary Post (Part 2)
This second installment in our two-part series features Dr. Stacey Clardy in conversation with Mary Post, CEO of the American Academy of Neurology.
June 24, 2021 Issue
SPECIAL REPORT on Aducanumab Approval: A Pulitzer Prize-winning Journalist's Perspective
Dr. Gregg Day speaks with Pam Belluck, an award-winning journalist at the New York Times, about her coverage of the recent FDA approval of aducanumab for Alzheimer disease treatment.
Disclosures can be found at Neurology.org.
June 22, 2021 Issue
SPECIAL REPORT: A Discussion With Mary Post (Part 1)
This first installment in our two-part series features Dr. Stacey Clardy in conversation with Mary Post, CEO of the American Academy of Neurology.
June 19, 2021 Issue
SPECIAL REPORT on Aducanumab Approval: Discussion with Cognitive Behavioral Neurologists
Dr. Jeff Burns, Director of the University of Kansas Alzheimer’s Disease Center, speaks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Center, about the recent FDA approval of aducanumab for the treatment of Alzheimer disease.
Disclosures can be found at Neurology.org.
June 17, 2021 Issue
SPECIAL REPORT on Aducanumab Approval: Steve Pearson of ICER Discusses the Economic and Clinical Impact
Dr. Jason Crowell speaks with Dr. Steve Pearson, President of the Institute for Clinical and Economic Review, about the clinical and economic impact of aducanumab, a drug recently approved by the FDA for the treatment of Alzheimer disease.
Disclosures can be found at Neurology.org.
June 15, 2021 Issue
A Discussion With Dr. John Quinlan; Readmission Risk for RCVS
The first segment features Dr. Stacey Clardy in conversation with 2021 Ted Burns Humanism in Neurology Award recipient Dr. John Quinlan. In the second part of the podcast, Dr. Andy Southerland discusses the risk of readmission following inpatient admission for reversible cerebral vasoconstriction syndrome with Dr. Santiago Ortega-Gutierrez.
Disclosures can be found at Neurology.org.
June 8, 2021 Issue
Physical Therapy Referrals For Back Pain; The SELECT Trial for Large Vessel Occlusion
In the first segment, Dr. Jeff Ratliff discusses primary care management for acute sciatica and physical therapy referrals with Dr. Julie Fritz. In the second part of the podcast, Dr. Andy Southerland talks with Dr. Amrou Sarraj about efficacy and safety of direct endovascular thrombectomy compared to bridging therapy in patients with large vessel occlusions.
Disclosures can be found at Neurology.org.
June 2, 2021 Issue
Alzheimer's Disease Diagnostics & Treatments (Neurology Recall June 2021)
This month's replay of past episodes showcases a selection of interviews by Drs. Jeff Burns, Jason Crowell, and Gregg Day on updates in Alzheimer's disease diagnostics and the impact of future therapies, featuring Drs. Michael Weiner, Randall Bateman, Erik Musiek, Joseph Therriault, and Yvette Sheline.
Disclosures can be found at Neurology.org.
June 1, 2021 Issue
Concussion Biomarkers in Saliva; Non-invasive Biomarkers of Intracranial Pressure
In the first segment, Dr. Alex Menze speaks with Prof. Antonio Belli about the role of salivary small non-coding RNAs in the diagnosis of sport-related concussion. In the second part of the podcast, the interviewer talks to Dr. Linda D’Antona about the utility of brain MRI and ophthalmic biomarkers for the prediction of intracranial hypertension.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
May 24, 2021 Issue
Pregnancy and Stroke; Myasthenia Gravis and Pregnancy
In the first segment, Dr. Stacey Clardy speaks with Dr. Petra Ijäs about the incidence of stroke during pregnancy or puerperium in Finland from 1987-2016. In the second part of the podcast, the interviewer talks with Dr. Emma Ciafaloni about management of pregnancy in myasthenia gravis.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
May 18, 2021 Issue
Natural History of PLS; Stratifying Risk in ICH
In the first segment, Dr. Jason Crowell discusses a natural history study of “pure” primary lateral sclerosis with Dr. Anhar Hassan. In the second part of the podcast, Dr. Andy Southerland talks with Dr. Roland Faigle about the assessment of critical care needs for patients with spontaneous intracerebral hemorrhage.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
May 11, 2021 Issue
Developing a Brain Machine Interface; Association of Huntington CAG Repeats With Cognition
In the first segment, Dr. Andy Southerland talks with Dr. Mijail Serruya about developing a brain-machine interface for patients with stroke. In the second part of the podcast, Dr. Jason Crowell discusses the relationship between CAG repeat length and cognition in adult patients with Dr. Jordan Schultz.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
May 4, 2021 Issue
Diagnostic Criteria for Traumatic Encephalopathy Syndrome; Trends in Neurology Drug Payments
In the first segment, Dr. Alex Menze talks to Dr. Robert Stern about developing NINDS consensus diagnostic criteria for traumatic encephalopathy syndrome. In the second part of the podcast, Dr. Jason Crowell speaks with Dr. Adam de Havenon about five-year cost trends and utilization of neurologist-prescribed drugs for Medicare Part D beneficiaries.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
May 1, 2021 Issue
History of the Neurologic Exam (Neurology Recall May 2021)
This month's replay of past episodes features a selection of Neurology Minute segments in which Dr. Chris Boes discusses the history of neurology and the neurologic exam.
Disclosures can be found at Neurology.org.
April 27, 2021 Issue
Long Term Effects of Cholinesterase Inhibitors; Pharmacovigilance in MS
In the first segment, Dr. Jeff Burns speaks with Prof. Maria Eriksdotter about whether Cholinesterase inhibitors are associated with slower cognitive decline and decreased mortality risk. In the second part of the podcast, the interviewer talks with Dr. Martijn Wijburg about pharmacovigilance of patients treated with disease-modifying therapies for MS.
Disclosures can be found at Neurology.org.
April 22, 2021 Issue
SPECIAL REPORT: Update on the Johnson & Johnson COVID-19 Vaccine and Blood Clot Risk
Dr. Derek Stitt speaks with FDA Center for Biologics Evaluation and Research Director Dr. Peter Marks about cases of thrombosis after the Johnson & Johnson COVID-19 vaccine, potential risk factors, and suggestions for patient care.
Disclosures can be found at Neurology.org.
April 20, 2021 Issue
Chronic Immune Sensory Polyradiculopathy; Ethical Issues in Neurology Research
In the first segment, Dr. Ted Burns talks with Drs. P. James B. Dyck and Shahar Shelly about clinical, neurophysiological, and pathological features of CISP-plus in comparison to CISP. In the second part of the podcast, the interviewer discusses important ethical issues encountered in neurological clinical research with Dr. Benjamin Tolchin.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
April 13, 2021 Issue
Pregnancy and NMO; COVID-19 Health Disparities
In the first segment, the interviewer talks with Dr. Nicolas Collongues about pregnancy in patients with neuromyelitis optica spectrum disorder. In the second part of the podcast, Dr. Jason Crowell discusses racial and ethnic health disparities exacerbated by COVID-19 with Drs. Leo Lopez III and Louis Hart.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
April 6, 2021 Issue
Financial COIs in Neurology Journals; Direct to Consumer Alzheimer's Testing
In the first segment, Dr. Stacey Clardy talks to Jade Smith about financial conflicts of interest of authors published in high-impact neurology journals. In the second part of the podcast, Dr. Jason Crowell speaks with Dr. Emily Largent about potential advancements and ethical challenges associated with blood testing for Alzheimer disease.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
April 1, 2021 Issue
Updates in Epilepsy (Neurology Recall April 2021)
This month's replay of past episodes features four segments in which Dr. Fábio Nascimento discusses the diagnosis and management of epilepsy with Drs. Elizabeth Thiele, Helen Cross, Orrin Devinsky, and Atul Maheshwari. For discussion questions for your next journal club talk, go here.
Disclosures can be found at Neurology.org.
March 30, 2021 Issue
Seizure Frequency and Treatment During Pregnancy; Genetic Testing in Epileptic Encephalopathy
In the first segment, Dr. Halley Alexander speaks with Dr. Page Pennell about seizure frequency and treatment during pregnancy. In the second part of the podcast, Dr. Stacey Clardy talks with Dr. Elizabeth Emma Palmer about genetic testing in epileptic encephalopathy. Access resources for clinicians and families with information on when to consider genetic testing for epilepsy, what tests are available, and what their advantages or limitations may be.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
March 23, 2021 Issue
Portrait of a Parent With Alzheimer's; Bimagrumab in Inclusion Body Myositis
In the first segment, the interviewer speaks with Prof. Yvonne Latty about her personal experience of having a parent with Alzheimer disease. In the second part of the podcast, Dr. Stacey Clardy talks with Dr. Anthony Amato about bimagrumab in sporadic inclusion body myositis.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
March 16, 2021 Issue
Occipital Neuralgia; Are we ready for gene testing in Parkinson’s?
In the first segment, Dr. Teshamae Monteith talks with Dr. Paul Mathew on the prevalence of occipital neuralgia at a community hospital-based headache clinic. In the second part of the podcast, Dr. Jeffrey Ratliff talks with Drs. Lola Cook and Roy Alcalay about genetic testing for Parkinson disease.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
March 9, 2021 Issue
Prolonged Unconsciousness in COVID-19; Making the Diagnosis of Brain Death
In the first segment, Dr. Jeff Ratliff talks with Dr. Wilson Abdo about prolonged unconsciousness in COVID-19. In the second part of the podcast, the interviewer discusses making the diagnosis of brain death with Dr. Panayiotis Varelas.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
March 2, 2021 Issue
Disease Modifying Therapy in Alzheimer’s Disease; Tenecteplase vs Alteplase in Basilar Occlusion
In the first segment, Dr. Jason Crowell talks to Dr. Erik Musiek about disease-modifying therapy in Alzheimer disease. In the second part of the podcast, Dr. Andrew Southerland talks with Dr. Fana Alemseged about tenecteplase versus alteplase in basilar artery occlusion.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
March 1, 2021 Issue
Prion Diseases (Neurology Recall March 2021)
This month's Neurology Recall features Dr. Jason Crowell discussing prion diseases with both Dr. Sonia Vallabh and Nobel Prize Winner Dr. Stanley Prusiner.
Disclosures can be found at Neurology.org.
February 23, 2021 Issue
TIA: Admit or Follow Up?; Update in Epilepsy Part 4
In the first segment, Will Rondeau speaks with Dr. Sidsel Hastrup about inpatient vs outpatient management of TIA and stroke. In the second part of the podcast, Dr. Fabio Nascimento talks with Dr. Atul Maheshwari in the final part of our four-part series called Update in Epilepsy.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
February 16, 2021 Issue
Frequency of Biologically-defined Alzheimer’s; Update in Epilepsy Part 3
In the first segment, Dr. Gregg Day talks with Dr. Joseph Therriault on the frequency of biologically defined Alzheimer’s. In the second part of the podcast, Dr. Fabio Nascimento talks with Dr. Orrin Devinsky in the third part of a four-part series called Update in Epilepsy.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
February 9, 2021 Issue
Latest Lyme Disease Guidelines; Update in Epilepsy Part 2
In the first segment, Dr. Jason Crowell talks with Dr. Jeffrey Rumbaugh about the latest Lyme Disease Guidelines. In the second part of the podcast, Dr. Fabio Nascimento talks with Dr. Helen Cross in the second part of a four-part series called Update in Epilepsy.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
February 3, 2021 Issue
Update in Migraine (Neurology Recall February 2021)
This month's replay of past episodes features clinical pearls, diagnosis, and treatment of migraine with Dr. Teshamae Monteith. For discussion questions for your next journal club talk, go here.
Disclosures can be found at Neurology.org.
February 2, 2021 Issue
Predicting Seizure Recurrence via Brain Networks; Update in Epilepsy Part 1
In the first segment, Dr. Halley Alexander talks to Dr. Nishant Sinha about predicting seizure recurrence via brain networks. In the second part of the podcast, Dr. Fabio Nascimento talks with Dr. Elizabeth Thiele in the first part of a four-part series called Update in Epilepsy.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
January 26, 2021 Issue
Neurology and COVID-19 in NYC; Immigrant Neurologists in the US
In the first segment, Dr. Jason Crowell speaks with Dr. Jennifer Frontera about neurology and COVID-19 in New York City. In the second part of the podcast, Dr. Jeffrey Ratliff talks with Dr. Abhimanyu Mahajan and Dr. Erica Schuyler about immigrant neurologists in the United States.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
January 19, 2021 Issue
Update on the management of MG
Dr. Stacey Clardy receives an update from Dr. Pushpa Narayanaswami on the management of myasthenia gravis.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
January 15, 2021 Issue
SPECIAL REPORT: Patients’ out of pocket costs in neurology
Dr. Stacey Clardy talks with Dr. Chloe Hill about increasing out-of-pocket costs for privately-insured patients to obtain neurologic diagnostic services.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
January 12, 2021 Issue
Latest on cryptogenic stroke; Worldwide impact of NMO
In the first segment, Will Rondeau talks with Dr. Lee Schwamm about the latest on cryptogenic stroke. In the second part of the podcast, you’ll hear Dr. Stacey Clardy’s interview with Dr. Zsolt Laszlo Illés about the worldwide impact of neuromyelitis optica.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
January 5, 2021 Issue
The research and work of NAM inductee Merit Cudkowicz; Antibody therapy for pregnant women with MS
In the first segment, Dr. Stacey Clardy talks to National Academy of Medicine inductee Dr. Merit Cudkowicz about her research and work. In the second part of the podcast, Dr. Clardy talks with Dr. Katharina Fink about antibody therapy for pregnant women with multiple sclerosis.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology: Clinical Practice®, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
January 1, 2021 Issue
Parkinson Disease (Neurology Recall January 2021)
Podcast founding editor Dr. Ted Burns introduces our Neurology Recall on Parkinson disease (PD), which features short segments discussing non-motor clinical manifestations, treatment options for motor manifestations, and recent advances in PD. This is a compilation of contributions to the Neurology Minute™ from the past 22 months since its launch in February 2019.
Disclosures can be found at Neurology.org.
December 29, 2020 Issue
SPECIAL REPORT: Looking ahead at COVID in 2021 with Dr. Avi Nath, Part 2
Dr. Avi Nath discusses update on the vaccines, how things are going in schools, and what we might expect in 2021.
Disclosures can be found at Neurology.org.
December 22, 2020 Issue
SPECIAL REPORT: Looking ahead at COVID in 2021 with Dr. Avi Nath, Part 1
Dr. Avi Nath discusses update on the vaccines, how things are going in schools, and what we might expect in 2021.
Disclosures can be found at Neurology.org.
December 16, 2020 Issue
SPECIAL REPORT: Headache Management in 2020
Drs. Monteith and Silberstein discuss all the new medications, and how and when to use them.
Disclosures can be found at Neurology.org.
December 15, 2020 Issue
Gender Representation in AAN Leadership, Publication, and Awards; Posterior Cortical Atrophy
In the first segment, Dr. Teshamae Monteith talks with Dr. Janis Miyasaki about gender representation in AAN leadership, publication, and awards. In the second part of the podcast, Dr. Jason Crowell speaks with journalist Jamie Talan about posterior cortical atrophy.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
December 8, 2020 Issue
Framing Discussions on Palliative Care in Neurology; Diagnosing Functional Neurologic Disorders
In the first segment, the interviewer talks with Dr. April Zehm about her Neurology: Clinical Practice paper regarding Framing Discussions on Palliative Care in Neurology. In the second part of the podcast, you’ll hear an interview with Dr. David Perez on Diagnosing Functional Neurologic Disorders.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology: Clinical Practice®, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
December 2, 2020 Issue
Stroke Basics (Neurology Recall December 2020)
This month's replay of past episodes features talks to help with the basics of treatment and prevention of stroke. This month highlights 3 segments featuring Dr. Dan Ackerman talking with Dr. Andrew Southerland, in a comprehensive talk on the care of stroke patients. Here are some questions and topics you might want to discuss at your journal club after you have listened to the November 2020 (1 &2) and December (3, 4 & 5) 2020 Neurology Recall on Stroke Management.
Disclosures can be found at Neurology.org.
December 1, 2020 Issue
Diagnostic Criteria for Idiopathic Sensory Polyneuropathy; The Research and Work of NAM Inductee Justin McArthur
In the first segment, Dr. Stacey Clardy talks with Dr. Roy Freeman about his paper discussing idiopathic distal sensory polyneuropathy. In the second part of the podcast, Dr. Clardy talks with Dr. Justin McArthur about his research, work, and the National Academy of Medicine Award.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz
November 24, 2020 Issue
Neural correlates of sign language production; Headache Quality Measurement Set
In the first segment, Dr. Jason Crowell talks with Dr. Jennifer Shum about her paper on neural correlates of sign language production. In the second part of the podcast, the interviewer speaks with Dr. Matthew Stuart Robbins on the Headache Quality Measurement Set.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz
November 17, 2020 Issue
Language, Words, and Neurology; Apathy and ICDs in Parkinson's Disease
In the first segment, Dr. Jason Crowell speaks with Dr. Martha Barnette of the 'A Way with Words' podcast about language, words, and neurology. In the second part of the podcast, Dr. Jeffrey Ratliff talks with Dr. Bonnie Scott about her paper on apathy and impulse control disorders in Parkinson's disease.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
November 15, 2020 Issue
SPECIAL REPORT: Changing Neurology Education
Dr. Ima Ebong and Dr. Eseosa Ighodaro discuss the changes in neurology education surrounding racial disparities.
Disclosures can be found at Neurology.org.
November 10, 2020 Issue
Effect of escitalopram on CSF Aβ; Neural effects of oxytocin in FTD
In the first segment, Dr. Jeff Burns talks with Dr. Yvette Sheline about her paper on the Effect of escitalopram on CSF Aβ. In the second part of the podcast, Dr. Stacey Clardy speaks with Dr. Elizabeth Finger about her article on the neural effects of oxytocin on frontotemporal dementia, also from this week’s issue.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
November 3, 2020 Issue
Predicting Treatment Response in Generalized Epilepsy; Dissociated Motor Learning in Functional Gait Disorders
In the first segment, Dr. Derek Bauer talks with Dr. Christoph Beier about his paper on predicting treatment response in generalized epilepsy. In the second part of the podcast, the interviewer speaks with Dr. Diego Kaski about his Brain article on dissociated motor learning in functional gait disorders. Read the article here: https://bit.ly/36JjFOP.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
November 1, 2020 Issue
Stroke Basics (Neurology Recall November 2020)
This month's replay of past episodes features talks to help with the basics of treatment and prevention of stroke. This month highlights 2 segments featuring Dr. Dan Ackerman talking with Dr. Andrew Southerland, in a comprehensive talk on the care of stroke patients.
Disclosures can be found at Neurology.org.
October 27, 2020 Issue
Blood tests for Alzheimer’s Disease; Subcortical involvement in TBI
In the first segment, Dr. Jeff Burns speaks with Dr. Michael Weiner about his New York Times article on blood tests for Alzheimer’s disease. Read the NYT article here: https://nyti.ms/3cKheMW. Next, the interviewer talks with Dr. Martin Monti about his Neurology Journal paper on subcortical involvement in traumatic brain injury.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
October 20, 2020 Issue
Super-refractory status epilepticus; Neurologic sequela in sledding athletes
In the first segment, Dr. Jeffrey Ratliff talks with Dr. Elizabeth Matthews about her paper on super-refractory status epilepticus. In the second part of the podcast, Dr. Jason Crowell speaks with Matthew Futterman about his New York Times article on neurologic sequela in sledding athletes. Read the NYT article here: https://nyti.ms/3mNBlhE.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
October 13, 2020 Issue
Diagnosing arm tremor; Extracellular matrix protein in cervical artery dissection
In the first segment, Dr. Jeffrey Ratliff speaks with Dr. A.M. Madelein van der Stouwe about her Journal of Neurology, Neurosurgery, and Psychiatry article on diagnosing arm tremor. Read the article here: https://bit.ly/3iETrQD. In the second part of the podcast, Dr. Andrew Southerland talks with Dr. Michael Knoflach and Dr. Lukas Mayer about their paper discussing extracellular matrix protein in cervical artery dissection.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
October 6, 2020 Issue
Profile of Prion disease – in both research and life, pt. 2; Ocrelizumab and vaccination in MS
In the first segment, Dr. Jason Crowell continues his discussion with Dr. Sonia Vallabh on a profile of prion disease, in the second part of a 2-part interview. Next, the interviewer talks with Dr. Amit Bar-Or about his paper discussing vaccine response in patients with MS.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
October 1, 2020 Issue
Movement Disorder Emergencies (Neurology Recall October 2020)
In this month's replay of past episodes, we cover movement disorder emergencies, featuring discussion between podcast editors Dr. Jeffrey Ratliff and Dr. Jason Crowell, from July 13th and 20th. For discussion questions for your next journal club talk, go here.
Disclosures can be found at Neurology.org.
September 29, 2020 Issue
Profile of Prion disease – in both research and life (part 1); Visual processing in visual snow syndrome
In the first part of the podcast, Dr. Jason Crowell speaks with Dr. Sonia Vallabh about her life and work in prion disease, in the 1st part of a 2-part series. Dr. Vallabh has been profiled in WIRED and the New York Times. Next, Dr. Teshamae Monteith talks with Dr. Joanne Fielding about her paper discussing visual processing in visual snow syndrome.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
September 22, 2020 Issue
Copaxone and drug pricing; Ultrasound-guided Lumbar Puncture
In the first segment, Dr. Jason Crowell talks with Eric Pachman about his report on copaxone and drug pricing. Next, Dr. Jeffrey Ratliff talks with Dr. Yi Li about her Neurology: Clinical Practice paper discussing ultrasound-guided lumbar puncture.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology: Clinical Practice®, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
September 15, 2020 Issue
Managing ischemic stroke pt. 5; Paranodal antibodies in acute autoimmune neuropathy
In the first segment, Dr. Dan Ackerman and Dr. Andrew Southerland finish their discussion on managing ischemic stroke, in the 5th of a 5-part series. Next up, Dr. Stacey Clardy talks with Dr. Luise Appeltshauser about her paper discussing paranodal antibodies in acute autoimmune neuropathy.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology: Clinical Practice®, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
September 8, 2020 Issue
Managing ischemic stroke, pt. 4; Cost of Surgery for Temporal Lobe Epilepsy in the US
Dr. Dan Ackerman and Dr. Andrew Southerland continue their discussion on managing ischemic stroke, in the 4th of a 5-part series. Dr. Jason Crowell talks with Dr. Lara Jehi about her paper discussing surgery costs in temporal lobe epilepsy.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
September 4, 2020 Issue
Treatment of Status Epilepticus (Neurology Recall September 2020)
In this month's replay of past episodes, we cover treatment and management of status epilepticus, featuring discussion between Dr. Halley Alexander and Dr. Michael Sperling. For discussion questions for your next journal club talk, go here.
Disclosures can be found at Neurology.org.
September 1, 2020 Issue
Managing ischemic stroke, pt. 3; Brain-responsive neurostimulation for focal epilepsy
Dr. Dan Ackerman and Dr. Andrew Southerland continue their discussion on managing ischemic stroke, in the 3rd of a 5-part series. In the second segment, Dr. Halley Alexander talks with Dr. Martha Morrell about her paper discussing neurostimulation in focal epilepsy.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
August 25, 2020 Issue
The Management of Acute Stroke Part 2; Diagnostic Testing for Prion Disease
In the 2nd of a 5-part series on managing ischemic stroke, Dr. Andrew Southerland talks with Dr. Dan Ackerman. Dr. Gregg Day talks with Dr. Brian Appleby about his paper discussing diagnostic testing for prion disease.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
August 18, 2020 Issue
The Management of Acute Stroke Part 1; Phenoconversion in Pure Autonomic Failure
In the 1st of a 5-part series on managing ischemic stroke, Dr. Andrew Southerland talks with Dr. Dan Ackerman. Dr. Stacey Clardy talks with Dr. Elizabeth Coon about her paper discussing phenoconversion in pure autonomic failure.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
August 11, 2020 Issue
Mortality of patients with non-epileptic seizures; Plasticity of Functionally Connected Motor Networks
In the first segment, the interviewer talks with Dr. Terence O'Brien about his paper on mortality in patients with non-epileptic seizures. Next, Dr. Jeffrey Ratliff talks with Dr. Nico Dosenbach about plasticity of functionally connected motor networks. Read Dr. Dosenbach's paper in Neuron: https://www.sciencedirect.com/science/article/abs/pii/S0896627320303536?via%3Dihub.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
August 4, 2020 Issue
Thought to Text Technology; Can experts predict outcomes of clinical trials?
In the first segment, Dr. Andrew Southerland speaks with Dr. J.G. Makin about his Nature article on thought-to-text technology. Then, Dr. Jason Crowell talks with Dr. Jonathan Kimmelman about his paper on expert crowd prediction on clinical trial response. Dr. Makin's article is available online at: https://www.nature.com/articles/s41593-020-0608-8.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
July 28, 2020 Issue
Update on Neuro-Oncology; DBS in Early PD
In the first segment, Dr. Kathryn Nevel and Dr. Jennie Taylor discuss neuro-oncology. Next, Dr. Jeffrey Ratliff talks with Dr. David Charles about his paper discussing deep brain stimulation in early Parkinson disease.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
July 21, 2020 Issue
Movement Disorder Emergencies Part 2; Patient and Public Involvement in Clinical Trials
In the first part of the podcast, Dr. Jeffrey Ratliff and Dr. Jason Crowell continue their discussion on movement disorder emergencies in the 2nd part of a 2-part dialogue. In the second segment, Dr. Stacey Clardy talks with Dr. Holly Hinson about her Neurology: Clinical Practice editorial on patient and public involvement in clinical trials from the June 2020 issue.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology: Clinical Practice®, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
July 14, 2020 Issue
Movement Disorder Emergencies Part 1; Maintenance Therapy for MOG-IgG Disorder
In the first segment, you’ll hear the first part of a 2-part conversation between Dr. Jeffrey Ratliff and Dr. Jason Crowell on movement disorder emergencies. In the second segment, Dr. Stacey Clardy talks with Dr. John Chen about his Neurology paper discussing maintenance therapy for MOG-IgG disorder.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
July 7, 2020 Issue
Allele-Selective Therapy in HD; Telephone based CBT In Parkinson’s
In the first segment, Dr. Jason Crowell talks with Dr. Daniel Claassen about his Neurology: Genetics paper on genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease. In the second part of the podcast, Dr. Jeffrey Ratliff focuses his discussion with Dr. Roseanne Dobkin on telephone-based CBT for depression in patients with Parkinson disease.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology: Clinical Practice®, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
June 30, 2020 Issue
Managing Status Epilepticus, part 2
In the 2nd part of this 2-part series, Dr. Halley Alexander interviews Dr. Michael Sperling about management of status epilepticus.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology: Clinical Practice®, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation, or from articles from issues for which a CME exam has previously been issued, are excluded from the CME program.
June 23, 2020 Issue
Managing Status Epilepticus, part 1
In the 1st part of this 2-part series, Dr. Halley Alexander interviews Dr. Michael Sperling about management of status epilepticus.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology: Clinical Practice®, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation, or from articles from issues for which a CME exam has previously been issued, are excluded from the CME program.
June 16, 2020 Issue
Diagnosing Neurosarcoidosis; Use of Progenitor Cells in Parkinson Disease
1. Distinguishing neurosarcoidosis from multiple sclerosis based on cerebrospinal fluid analysis: A retrospective study
2. What’s Trending: Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease
In the first segment, the interviewer talks with Dr. Tarunya Arun about her paper discussing diagnosis of neurosarcoidosis. In the second part of the podcast, Dr. Jeffrey Ratliff talks with Dr. Jeffrey Schweitzer about his NEJM paper discussing progenitor cells for Parkinson disease. Read the NEJM article here: https://bit.ly/2XjHvuc.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
June 9, 2020 Issue
Managing Migraine, pt. 2; NFL as a biomarker after mild TBI
1. Migraine and the under- and uninsured, pt. 2
2. NFL as a biomarker after mild TBI
In the first segment, you'll hear the second part of an interview on migraine between Dr. Jason Crowell and Dr. David Watson, focusing on special patient populations in management of migraine. In the second segment, the interviewer talks with Dr. Kimbra Kenney and Dr. Jessica Gill about their paper on NFL as a biomarker following traumatic brain injury.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
June 2, 2020 Issue
Managing Migraine; How to improve using Quality Outcomes Measurement Sets
1. Migraine and the under- and uninsured, pt. 1
2. How to improve using Quality Outcomes Measurement Sets
In the first segment, Dr. Jason Crowell talks with Dr. David Watson about managing migraine in the first part of a two-part series. In the second segment, Dr. Jeff Ratliff talks with Dr. Jason Jonathan Sico about his Neurology paper on improving quality outcomes measurement sets. Part of the information in the discussion with Dr. Watson can be found in this paper in Current Pain and Headache Reports: https://link.springer.com/article/10.1007/s11916-019-0749-1.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
May 26, 2020 Issue
Insomnia Treatment in the Elderly; Living with Huntington's Part 2
1. Daridorexant, a new dual orexin receptor antagonist, in elderly subjects with insomnia disorder
2. Living with Huntington’s, pt. 2
In the first segment, Dr. Jeffrey Ratliff talks with Dr. Yves Dauvilliers about their paper on insomnia treatment in the elderly. In the second part of the podcast, Dr. Jason Crowell continues his talk with Dr. Nancy Wexler about living with Huntington's disease.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
May 19, 2020 Issue
Living with Huntington's Disease (part 1); Latest on PFO and stroke
1. Living with Huntington's Disease, pt. 1
2. Latest on PFO and stroke
In the first segment, you'll hear the first part of an interview between Dr. Jason Crowell and Dr. Nancy Wexler on living with Huntington's disease. In the second segment, Dr. Andrew Southerland talks with Dr. Steven Messe on his practice advisory update summary paper on patent foramen ovale and secondary stroke prevention.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
May 12, 2020 Issue
Treatment of Adult ADHD; Surrogates' Decisions after Acute Brain Injury
1. Treatment of Adult ADHD
2. Surrogates' Decisions after Acute Brain Injury
In the first segment, Dr. Teshamae Monteith talks with Dr. Scott Hirsch about treatment of adult ADHD. In the second segment, the interviewer talks with Dr. David Hwang about his Neurology paper on factors impacting surrogate decision makers for acute brain injury patients.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
May 6, 2020
SPECIAL REPORT: Dr. Renee Shellhaas on Demonstrating Courage in a Time of Uncertainty
Dr. Jason Crowell talks with Dr. Renee Shellhaas on courage during COVID-19 and on demonstrating leadership as neurologists in these circumstances. Read Dr. Shellhaas' special editorial: https://n.neurology.org/content/early/2020/04/24/WNL.0000000000009496. For a clearing house of neurology related information on the coronavirus go to https://www.aan.com/tools-and-resources/covid-19-neurology-resource-center/ to stay up-to-date.
May 5, 2020 Issue
Epilepsy in the Elderly; Scrambling Pain in NMO
1. What’s Trending: Epilepsy in the elderly
2. Scrambler therapy improves pain in neuromyelitis optica: A randomized controlled trial
In the first segment, Dr. Jeff Ratliff speaks with Dr. Scott Mintzer about epilepsy in the elderly. In the second segment, Dr. Jeff Ratliff talks with Dr. Maureen Mealy about her paper on the use of scrambler therapy for pain in neuromyelitis optica.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
April 30, 2020
SPECIAL REPORT: Dr. Thomas Oxley talks about stroke with COVID-19 in the young
The interviewer talks with Dr. Thomas Oxley about stroke as a presenting feature of COVID-19 in the young. Read Dr. Oxley's special correspondence in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMc2009787. For a clearing house of neurology related information on the coronavirus go to https://www.aan.com/tools-and-resources/covid-19-neurology-resource-center/ to stay up-to-date.
April 28, 2020 Issue
An update on delirium; nocturnal blood pressure and cognition
1. What’s Trending: Joining Forces against Delirium — From Organ-System Care to Whole-Human Care
2. White matter hyperintensities mediate the association of nocturnal blood pressure with cognition
In the first segment, Dr. Greg Day speaks with Dr. Sharon Inouye about her NEJM article providing an update on delirium. The article is available online at: https://bit.ly/2UCh2Xo. In the second segment, Dr. Adam Brickman talks with Dr. Dan Ackerman about his Neurology paper on nocturnal blood pressure and cognition.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
April 25, 2020
SPECIAL REPORT: Neil Busis & Brad Klein make teleneurology easy & fun--tips for billing and physical exams
Dr. Jason Crowell talks with Dr. Neil Busis and Dr. Brad Klein about teleneurology, tips for billing, and exams during the COVID-19 pandemic. Read the special editorial by Drs. Busis and Klein: https://n.neurology.org/content/early/2020/04/24/WNL.0000000000009494. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.
April 23, 2020
SPECIAL REPORT: Dr. Ken Tyler dispels some of the misinformation about SARS-CoV2, & gives updates on antibody testing and ongoing clinical trials
Dr. Stacey Clardy talks with Dr. Ken Tyler about misinformation about SARS-CoV2 & gives updates on antibody testing and ongoing clinical trials. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.
April 21, 2020 Issue
Use of DWI after cardiac arrest; Eptinezumab for migraine
1. Prognostic value of diffusion-weighted MRI for post-cardiac arrest coma
2. PROMISE-2: Efficacy and safety of eptinezumab in patients with chronic migraine (Neurology®, March 31)
In the first segment, Dr. Rae Bacharach talks with Dr. Karen Hirsch about her paper on the prognostic value of diffusion-weighted MRI for post-cardiac arrest coma. In the second part of the podcast, Dr. Teshamae Monteith speaks with Dr. Richard Lipton about his Neurology® paper on eptinezumab for migraine, from the March 31st issue.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
April 17, 2020
SPECIAL REPORT: On being a neurologist in Italy during the COVID-19 pandemic
Dr. Jeff Ratliff talks with Dr. Anna Bersano about being a neurologist in Italy during the COVID-19 pandemic. Read Dr. Bersano's special editorial in Neurology: https://n.neurology.org/content/early/2020/04/01/WNL.0000000000009508. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.
April 15, 2020
SPECIAL REPORT: Ethics in the time of COVID, w/ expert opinion from Dr. Scott Kim of NIH
The interviewer talks with Dr. Scott Kim about ethics in the time of COVID-19. Read Dr. Kim's editorial in Neurology: https://n.neurology.org/content/early/2020/04/06/WNL.0000000000009520. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.
April 14, 2020 Issue
Neurology on the Hill; Multiple hit theory of ALS
1. Neurology on the HIll
2. ALS is a multi-step process in South Korean, Japanese, and Australian patients (Neurology®: April 14)
In the first segment, Dr. Jason Crowell speaks with Dr. Andrew Southerland about Neurology on the Hill. In the second part of the podcast, Dr. Matthew Harms talks with Dr. Steve Vucic about his paper on multiple hit theory of ALS.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
April 10, 2020
SPECIAL REPORT: Joseph Kvedar (Pres.-elect of American Telemed) & Teshamae Monteith discuss value-based care in telemedicine, telestroke, & e-consults--the future is NOW
Dr. Teshamae Monteith talks with Dr. Joseph Kvedar about value-based care, e-consults, and telemedicine. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.
April 8, 2020
SPECIAL REPORT: Tips to become a teleneurology expert w/ Drs. Melissa Ko & Teshamae Monteith
Dr. Teshamae Monteith talks with Dr. Melissa Ko about telemedicine for neurologists caring for patients in light of COVID-19. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.
April 7, 2020 Issue
Neural networks and DBS; Reconsidering biomarkers in Parkinson’s
1. Why Deep Brain Stimulation Works for Some People and Not Others (Neurology Today)
2. [What’s Trending]: Disease modification and biomarker development in Parkinson disease: Revision or reconstruction? (Neurology®: March 17)
In the first segment, Dr. Jeff Ratliff talks with Dr. Nico Dosenbach about his Neuron paper on neural networks and deep brain stimulation, and they specifically cover the Neurology Today article on this paper with respect to the impact on DBS. In the second part of the podcast, Dr. Jeff Ratliff speaks with Dr. Alberto Espay about his paper—from the March 17th issue of Neurology—on reconsidering biomarkers in Parkinson disease. You can read the Neurology Today story here: https://bit.ly/2TzJr0Y; and you can read the Neuron paper here: https://bit.ly/2TX1zku.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology: Clinical Practice®, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation, or from articles from issues for which a CME exam has previously been issued, are excluded from the CME program.
April 4, 2020
Special Report: Dr. Ian Lipkin of Columbia University (and advisor on the movie, Contagion) discusses COVID-19, including his own diagnosis & our role as neurologists
Dr. Ian Lipkin discusses his own diagnosis with COVID-19 and what neurologists can do in light of the pandemic to keep safe and to serve patients. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.
Find the cast of Contagion's PSAs on the pandemic: https://abcnews.go.com/Entertainment/cast-contagion-issues-psa-coronavirus-pandemic/story?id=69853838.
Find Columbia University's Control the Contagion page: https://www.publichealth.columbia.edu/controlthecontagion.
April 1, 2020
Functional Neurologic Disorders (Delayed Recall-April 2020)
This month’s Delayed Recall highlights 13 interviews on functional neurologic disorders from the series conducted with Jon Stone for the Neurology Minute podcast. The episodes aired between September 2019 and March 2020. In this series, Jon Stone discusses who is susceptible to FNDs, diagnosis of nonepileptic spells, the myth of FND as psychological disorders with psychological origins, the various treatments available to patients with functional neurologic disorders, and other topics.
March 31, 2020 Issue
Generic glatiramer acetate reduces MS costs; Med adherence and out of pocket costs?
1. Effect of generic glatiramer acetate on spending and use of drugs for multiple sclerosis
2. [What’s Trending]: Association between out-of-pocket costs and adherence to common neurologic medications
In the first segment, Dr. Jason Crowell speaks with Dr. Brian Callaghan about his paperon the association between out-of-pocket costs and adherence to common neurologic medications. In the second part of the podcast, Dr. Jason Crowell talks with Dr. Daniel Hartung about his paper—also from the March 31st issue of Neurology—on the effect of generic glatiramer acetate on the reduction of MS costs.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
March 24, 2020 Issue
Lewy Body Dementia management; Pathologic tearfulness after limbic encephalitis
1. New evidence on the management of Lewy body dementia
2. [What’s Trending]: Pathologic tearfulness after limbic encephalitis: A novel disorder and its neural basis
In the first segment, Dr. Matthew Barrett talks with Dr. John-Paul Taylor about his paper on Lewy body dementia management, from The Lancet. In the second part of the podcast, Dr. Stacey Clardy speaks with Dr. Chris Butler about his paper on pathologic tearfulness after limbic encephalitis. You can read Dr. Taylor’s paper in The Lancet here: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(19)30153-X/fulltext.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
March 17, 2020 Issue
"Future of Care" interview with John Noseworthy; Blood NFl levels - MS treatment effects
1. Preserving the patient-physician relationship, with Dr. John Noseworthy
2. [What’s Trending]: Blood NFl and MS treatment
In the first segment, Dr. Jason Crowell speaks with Dr. John Noseworthy on his NEJM article on preserving the physician-patient relationship, which you can read here: https://www.nejm.org/doi/full/10.1056/NEJMsr1912662. In the second part of the podcast, the interviewer talks with Dr. Frederik Piehl about his Neurology paper discussing how blood neurofilament-light levels segregate treatment effects in patients with multiple sclerosis.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
March 10, 2020 Issue
Enterovirus as cause of AFM; AEDs and cognition
1. Antiepileptic drugs are not independently associated with cognitive dysfunction
2. [What’s Trending]: Pan-viral serology implicates enteroviruses in acute flaccid myelitis
In the first segment, Dr. Halley Alexander talks with Dr. Emma Foster about her paper on her paper discussing that antiepileptic drugs are not independently associated with cognitive dysfunction. In the second part of the podcast, the interviewer speaks with Dr. Michael Wilson and Dr. Ryan Schubert on their article in Nature Medicine, “Pan-viral serology implicates enteroviruses in acute flaccid myelitis,” which you can read here: https://www.nature.com/articles/s41591-019-0613-1.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
March 3, 2020 Issue
Breastmilk transfer of Rituximab; modeling the price of good health
1. Minimal breastmilk transfer of rituximab, a monoclonal antibody used in neurological conditions (Neurology®: Neuroimmunology & Neuroinflammation)
2. [What’s Trending]: Obscure Model Puts a Price on Good Health—and Drives Down Drug Costs
In the first segment, the interviewer talks with Dr. Riley Bove about her paper on minimal breastmilk transfer of rituximab, a monoclonal antibody used in neurological conditions. In the second part of the podcast, Dr. Jason Crowell speaks with Denise Roland of the Wall Street Journal about her story on an obscure model driving down drug costs. You can read the article in the Wall Street Journal here: https://www.wsj.com/articles/obscure-model-puts-a-price-on-good-healthand-drives-down-drug-costs-11572885123.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
February 25, 2020 Issue
Managing Status Epilepticus; Neuroinflammation Review
1. Randomized trial of three anticonvulsant medications for status epilepticus
2. [What’s Trending]: Review of the future of neuroimmunology & neuroinflammation
In the first segment, Dr. Stacey Clardy talks with Dr. Robert Silbergleit and Dr. Jaideep Kapur about anticonvulsant medications for status epilepticus. In the second part of the podcast, the interviewer talks with Dr. Josep Dalmau and Dr. Francesc Graus about about the future of neuroimmunology and neuroinflammation. You can read Dr. Silbergleit and Dr. Kapur's paper in the New England Journal of Medicine here: https://www.nejm.org/doi/full/10.1056/NEJMoa1905795.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
February 18, 2020 Issue
Seronegative Anti-NMDA encephalitis; Infectious encephalitis
1. Clinical features of seronegative, but CSF antibody positive, anti-NMDA receptor encephalitism (Neurology: Neuroimmunology & Neuroinflammation)
2. [What’s Trending]: the year in infectious encephalitis and arthropod-borne infections
In the first segment, the interviewer talks with Dr. Josep Dalmau and Dr. Francesc Graus about their Neurology: Neuroimmunology & Neuroinflammation paper on clinical features of seronegative, but CSF antibody positive, anti-NMDA receptor encephalitis. In the second part of the podcast, Dr. Stacey Clardy talks with Dr. Ken Tyler about infectious encephalitis and arthropod-borne infections in 2019.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
February 11, 2020 Issue
Visual Snow; MS Drug Kickback Allegations
1. Visual snow syndrome: A clinical and phenotypical description of 1,100 patients
2. [What’s Trending]: Patient charity settles allegations it helped MS drug makers pay kickbacks
In the first segment, Dr. Teshamae Monteith talks with Dr. Francesca Puledda about her paper providing a clinical and phenotypical description of visual snow syndrome. In the second part of the podcast, Dr. Jason Crowell talks with Ed Silverman about the settlement over allegations that a patient charity helped MS drug makers pay kickbacks. You can read Mr. Silverman’s story in STAT: https://www.statnews.com/2019/11/20/patient-charity-allegations-ms-drug-makers-kickbacks/.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
February 4, 2020 Issue
Customized Gene Therapy; Quality Dementia Care
1. Quality improvement in dementia care: Dementia Management Quality Measurement Set 2018 implementation update
2. [What’s Trending]: Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
In the first segment, Dr. Jason Crowell talks with Dr. Timothy Yu about patient-customized oligonucleotide therapy for a rare genetic disease. In the second part of the podcast, Dr. Jeffrey Burns talks with Dr. Amy Sanders about her implementation update on quality improvement in dementia care. You can read Dr. Yu’s paper in the NEJM: https://www.nejm.org/doi/full/10.1056/NEJMoa1813279.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
January 28, 2020 Issue
Multiple Sclerosis Drug Pricing; CTE and American football
1. A qualitative study on the price of drugs for multiple sclerosis: “Gaming the system”
2. [What’s Trending]: Duration of American football play and chronic traumatic encephalopathy
In the first segment, Dr. Jason Crowell talks with Dr. Daniel Hartung about his qualitative study on drug prices for MS. In the second part of the podcast, the interviewer talks with Dr. Jesse Mez about the duration of American football play and chronic traumatic encephalopathy. You can read Dr. Mez’s paper in the Annals of Neurology: https://onlinelibrary.wiley.com/doi/10.1002/ana.25611.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
January 21, 2020 Issue
Brain volumes in professional fighters; Is colic related to migraine?
1. Longitudinal change in regional brain volumes with exposure to repetitive head impacts
2. [What’s Trending]: Infant colic and episodic syndromes
In the first segment, Dr. Jeffrey Ratliff talks with Dr. Charles Bernick about his paper on longitudinal change in regional brain volumes with exposure to repetitive head impacts. In the second part of the podcast, Dr. Teshamae Monteith talks with Dr. Amy Gelfand about infant colic and episodic syndromes.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
January 14, 2020 Issue
Hashimoto’s Encephalopathy; CaMEO Migraine study
1. Hashimoto encephalopathy in the 21st century
2. [What’s Trending]: Migraine Progression in Subgroups of Migraine Based on Comorbidities: Results of the CaMEO Study
In the first segment, Dr. Stacey Clardy talks with Dr. Francesc Graus and Dr. Josep Dalmau about their paper on Hashimoto encephalopathy in the 21st century. In the second part of the podcast, Dr. Teshamae Monteith talks with Dr. Richard Lipton and Dr. Dawn Buse about migraine progression in subgroups of migraine based on comorbidities.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
January 7, 2020 Issue
Gut microbiota and the vagus nerve; diagnosis of CMT
1. Targeted, next-generation, sequencing panels in the diagnosis of Charcot-Marie-Tooth disease
2. [What’s Trending]: Gut Microbe to Brain Signaling: What Happens in Vagus…
In the first segment, Dr. Michelle Mauermann talks with Dr. Mary Reilly about her paper on targeted, next-generation, sequencing panels in the diagnosis of Charcot-Marie-Tooth disease. In the second part of the podcast, the interviewer talks with Dr. Christine Fulling about gut microbiota and brain signaling via the vagus nerve to affect brain and behavior.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
December 30, 2019 Issue
History of and Reflections on the Neurology Podcast
This week, Dr. Ted Burns, creator and former editor of the Neurology Podcast, discusses the history, process, and meaning of the podcast.
December 24 2019 Issue
Metagenomics
This week, we feature past interviews with Dr. Mike Wilson on metagenomics.
December 17, 2019 Issue
Interview with Nobel Laureate Peter Doherty
Dr. Stacey Clardy talks with Nobel Laureate Peter Doherty about his collaborative work with Rolf Zinkernagel regarding how the body's immune system distinguishes virus-infected cells from normal cells, among many other topics.
December 10, 2019 Issue
Latest on Focused Ultrasound in ET; Statins and Intracerebral Hemorrhage
1. Three-year follow-up of prospective trial of focused ultrasound thalamotomy for essential tremor
2. Statins for Neuroprotection in Spontaneous Intracerebral Hemorrhage
In the first segment, Dr. Jason Crowell talks with Dr. Casey Halpern about his paper on a three-year follow-up of a prospective trial of focused ultrasound thalamotomy for essential tremor. In the second part of the podcast, Dr. Will Rondeau talks with Dr. Jared Chen and Dr. Andrew Southerland about statins for neuroprotection in spontaneous intracerebral hemorrhage.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
December 3, 2019 Issue
NMO Treatment Strategy; Prodromal Parkinson’s Disease
1. Treatment and prevention of neuromyelitis optica
2. Physical activity and prodromal features of Parkinson's disease
In the first segment, Dr. Ted Burns talks with Dr. Stacey Clardy about neuromyelitis optica. In the second part of the podcast, Dr. Jason Crowell talks with Dr. Alberto Ascherio about his paper on physical activity and prodromal features of Parkinson disease.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
November 26, 2019 Issue
Active forgetting in our sleep; improvement in pediatric demyelination
1. REM sleep–active MCH neurons are involved in forgetting hippocampus-dependent memories
2. [What’s Trending]: gnostic indicators of improvement with therapeutic plasma exchange in pediatric demyelination
In the first segment, the interviewer talks with Dr. Thomas Kilduff about his Science report article reporting that REM sleep–active MCH neurons are involved in forgetting hippocampus-dependent memories, which you can read here: https://science.sciencemag.org/content/365/6459/1308. In the second segment, Dr. Stacey Clardy talks with Dr. Sylvia Tenembaum about her paper on prognostic indicators of improvement with therapeutic plasma exchange in pediatric demyelination.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
November 19, 2019 Issue
Neurosyphilis; bothersome symptoms of PD
1. Neurosyphilis
2. [What’s Trending]: Symptom burden among individuals with Parkinson disease: A national survey (Neurology: Clinical Practice)
In the opening segment, the interviewer talks with Dr. Allan Ropper about his NEJM paper on neurosyphilis, which you can read here: https://www.nejm.org/doi/full/10.1056/NEJMx190030. In the second part, Dr. Jeffrey Ratliff talks with Dr. Christopher Tarolli about his Neurology: Clinical Practice paper on symptom burden among individuals with Parkinson disease.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
November 12, 2019 Issue
Neurologists’ responsibility for social health; update on pediatric migraine
1. Editorial: Social Health and Brain Health: Does neurology also have a duty to treat social ills?
2. [What’s Trending]: Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention
In the first segment, Dr. Jason Crowell talks with Dr. Joel Salinas about his editorial on neurologists’ duty to treat social ills. In the second part of the podcast, Dr. Teshamae Monteith talks with Dr. Andrew Hershey about his practice guideline update summary paper in Neurology® on pharmacologic treatment for pediatric migraine prevention. You can read "Practice Guideline Update: Pharmacologic Treatment for Pediatric Migraine Prevention" here: https://www.aan.com/Guidelines/home/GuidelineDetail/967. For further reading, there is also "Practice Guideline Update: Acute Treatment of Migraine in Children and Adolescents" here: https://www.aan.com/Guidelines/home/GuidelineDetail/966.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
November 5, 2019 Issue
Life of Oliver Sacks; Mi-2 dermatomyositis
1. More prominent muscle involvement in dermatomyositis patients with anti-Mi2 autoantibodies
2. [What’s Trending]: Lawrence Weschler discusses Oliver Sacks, pt. 2
In the first segment, Dr. Stacey Clardy continues her talk with Lawrence Weschler about his book on Oliver Sacks, And How are You, Dr. Sacks?, in the second of a two-part interview. In the second part of the podcast, Dr. Stacey Clardy talks with Dr. Andrew Mammen about his paper on more prominent muscle involvement in dermatomyositis patients with anti-Mi2 autoantibodies.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
October 29, 2019 Issue
Stem Cell Transplants for NMO and Looking Back on the Life of Oliver Sacks
1. Autologous, nonmyeloablative hematopoietic stem-cell transplantation for neuromyelitis optica
2. [What’s Trending]: Lawrence Weschler discusses Oliver Sacks, pt. 1
In the first segment, Dr. Stacey Clardy talks with Dr. Richard Burt about his paper on autologous, nonmyeloablative hematopoietic stem-cell transplantation for neuromyelitis optica. In the second part of the podcast, Dr. Stacey Clardy speaks with Dr. Lawrence Weschler about his book on Oliver Sacks, And How are You, Dr. Sacks?, in the first of a two-part interview.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
October 22, 2019 Issue
Testing Blood for Amyloid Beta-42 to Predict Future Brain Amyloidosis and Nobel Prize Winner Stanley Prusiner, pt. 2
1. Testing Blood for Amyloid Beta-42 to Predict Future Brain Amyloidosis
2. [What’s Trending]: Nobel Laureate Stanley Prusiner about his impact on neurology, pt. 2
In the first segment, Dr. Jeff Burns talks with Dr. Randall Bateman about his paper addressing how high precision plasma amyloid-β 42/40 predicts current and future brain amyloidosis. In the second part of the podcast, you'll hear the second part of an interview with Nobel Prize winner Dr. Stanley H. Prusiner.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
October 15, 2019 Issue
Clinical Management of Orthostatic Hypotension in PD and a discussion with Nobel Laureate Stanley Prusiner about his impact on neurology
1. Orthostatic hypotension in Parkinson disease: A 7-year prospective population-based study
2. [What’s Trending]: Nobel Laureate Stanley Prusiner about his impact on neurology, pt. 1
In the first segment, Dr. Jeffrey Ratliff talks with Dr. Ylva Hiorth and about their paper on a 7-year prospective population-based study on orthostatic hypotension in Parkinson disease. In the second part of the podcast, Dr. Jason Crowell talks with Nobel Prize winner Dr. Stanley B. Prusiner in the first of a two-part interview.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
October 8, 2019 Issue
Discussion of the WHO's Essential Diagnostics for Neurology and Evaluating Complement Antibody Therapy for NMO
1.The World Health Organization's essential diagnostics list: Diagnostics for neurologic disorders
2. [What's Trending]: Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
In the first segment, Dr. Greg Day talks with Dr. Kiran Thakur and Dr. Greer Waldrop about their paper on diagnostics for neurologic disorders on the World Health Organization’s essential diagnostic list. In the second part of the podcast, Dr. Stacey Clardy speaks with Dr. Sean Pittock on his NEJM paper on eculizumab in aquaporin-4–positive neuromyelitis optica spectrum disorder.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
October 1, 2019 Issue
Combination therapy with nusinersen and AVXS-101 in SMA type 1
1. Combination therapy with nusinersen and AVXS-101 in SMA type 1
2. [What's Trending]: Neuroimaging Findings in US Government Personnel With Possible Exposure to Directional Phenomena in Havana, Cuba
In the first segment, Dr. Jason Crowell talks with Dr. Emma Ciafaloni about her clinical/scientific note on combination therapy with nusinersen and AVXS-101 in SMA type 1. In the second part of the podcast, Dr. Jason Crowell speaks with Dr. Douglas Smith on neuroimaging findings in US government personnel with possible exposure to directional phenomena in Havana, Cuba.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
September 24, 2019 Issue
Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis
1.Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis
2. [What's Trending]: Drug pricing update, part 2
In the first segment, Dr. Stacey Clardy talks with Dr. Mauricio Farez about his practice guideline update summary on vaccine-preventable infections and immunization in multiple sclerosis. In the second part of the podcast, Dr. Gordon Smith continues his discussion with Dr. Steve Pearson on an update on drug pricing. Their previous discussion on drug pricing was featured in two parts on January 8th and January 15th, 2019.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
September 17, 2019 Issue
Understanding and addressing gender equity for women in neurology
1.Understanding and addressing gender equity for women in neurology
2. [What’s Trending]: Drug pricing update, part 1
In the first segment, Dr. Stacey Clardy talks with Dr. Julie Silver about her paper on understanding and addressing gender equity for women in neurology. In the second part of the podcast, Dr. Gordon Smith focuses his discussion with Dr. Steve Pearson on an update on drug pricing. Their previous discussion on drug pricing was featured in two parts on January 8th and January 15th, 2019.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
September 10, 2019 Issue
Varied Phenotypes and Management of Immune Checkpoint Inhibitor Associated Neuropathies
1. Varied Phenotypes and Management of Immune Checkpoint Inhibitor Associated Neuropathies
2. [What's Trending]: Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis
In the first segment, Dr. Noah Kolb talks with Dr. Amanda Guidon about her paper on varied phenotypes and management of immune checkpoint inhibitor associated neuropathies. In the second part of the podcast, Dr. Stacey Clardy focuses her discussion with Dr. Mike R. Wilson on clinical metagenomic sequencing for diagnosis of meningitis and encephalitis. Read the full NEJM article here: https://www.nejm.org/doi/full/10.1056/NEJMoa1803396.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
September 3, 2019 Issue
Therapy for acute nerve agent poisoning: An update (Neurology®: Clinical Practice)
1. Therapy for acute nerve agent poisoning: An update (Neurology®: Clinical Practice)
2. [What's Trending]: Detection of Brain Activation in Unresponsive Patients with Acute Brain Injury
In the first segment, Dr. Alex Menze talks with Dr. Jonathan Newmark about his Neurology: Clinical Practice paper that provides an update on therapy for acute nerve agent poisoning. In the second part of the podcast, Dr. Andrew Schomer focuses his discussion with Dr. Jan Claassen on detection of brain activation in unresponsive patients with acute brain injury. Read the full NEJM article here: https://www.nejm.org/doi/full/10.1056/NEJMoa1812757.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
August 27, 2019 Issue
A large case-control study on vaccination as risk factor of multiple sclerosis
1. A large case-control study on vaccination as risk factor of multiple sclerosis
2. [What's Trending]: Zika update 2019
In the first segment, the interviewer talks with Dr. Bernard Hemmer about his paper on a large case-control study on vaccination as risk factor of multiple sclerosis. In the second part of the podcast, Dr. Stacey Clardy focuses her discussion with Dr. Amanda Grennell on an update on Zika for 2019. Read the full article here: https://www.nature.com/articles/d41586-019-01906-z.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
August 20, 2019 Issue
A new paraneoplastic biomarker + Drug pricing controversies: “Evergreening” in pharma
1. Phosphodiesterase 10A-IgG: A novel biomarker of paraneoplastic neurological autoimmunity
2. [What’s Trending]: "Evergreening" and drug prices
In the first segment, Dr. Stacey Clardy talks with Dr. Anastasia Zekeridou about her paper on Phosphodiesterase 10A-IgG, a novel biomarker of paraneoplastic neurological autoimmunity. In the second part of the podcast, Dr. Jason Crowell focuses his discussion with Prof. Robin Feldman on “evergreening” and drug prices. Read the full article here: https://www.nature.com/articles/d41586-019-01906-z.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
August 13, 2019 Issue
Impulse control disorders in Parkinson disease and RBD: A longitudinal study of severity
1. Impulse control disorders in Parkinson disease and RBD: A longitudinal study of severity
2. [What’s Trending]: CRISPR babies: when will the world be ready?
In the first segment, Dr. Jason Crowell talks with Dr. Michele Hu and Dr. David Okai about their longitudinal study of the severity of impulse control disorders in Parkinson disease and RBD. In the second part of the podcast, Dr. Jason Crowell focuses his discussion with Dr. Heidi Ledford on her Nature article discussing CRISPR babies and what would be required to make gene editing safe and acceptable. Read the full article here: https://www.nature.com/articles/d41586-019-01906-z.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
August 6, 2019 Issue
Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS
1. Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS
2. [What's Trending]: Network localization of cervical dystonia based on causal brain lesions
In the first segment, Dr. Stacey Clardy talks with Dr. Robert Zivadinov about cumulative gadodiamide administration leading to brain gadolinium deposition in early MS. In the second part of the podcast, Dr. Jeffrey Ratliff focuses his discussion with Dr. Michael D. Fox on his Brain paper on network localization of cervical dystonia based on causal brain lesions. You can read the paper here: https://academic.oup.com/brain/article-abstract/142/6/1660/5491101?redirectedFrom=fulltext.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
July 30, 2019 Issue
CDC’s Guideline on Pediatric Mild Traumatic Brain Injury: Recommendations for Neurologists
1. CDC’s Guideline on Pediatric Mild Traumatic Brain Injury: Recommendations for Neurologists (Neurology: Clinical Practice)
2. [What's Trending]: Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
In the first segment, Dr. Kristen Heinan talks with Dr. Barbara Weissman about her Neurology: Clinical Practice paper on recommendations for neurologists on the CDC’s Guideline on Pediatric Mild Traumatic Brain Injury. In the second part of the podcast, Dr. Will Rondeau focuses his discussion with Dr. Geoffrey Donnan on his NEJM paper on thrombolysis guided by perfusion Imaging up to 9 hours after onset of stroke. You can read the paper here: https://www.nejm.org/doi/pdf/10.1056/NEJMoa1813046.
Disclosures can be found at Neurology.org.
July 23, 2019 Issue
Determining clinically meaningful decline in preclinical Alzheimer disease
1. Determining clinically meaningful decline in preclinical Alzheimer disease
2. [What's Trending]: Targeting Huntington expression in patients with Huntington's disease
In the first segment, Dr. Gregory Day talks with Dr. Philip Insel about his paper on determining clinically meaningful decline in preclinical Alzheimer disease. In the second part of the podcast, Dr. Sarah Tabrizi talks about targeting Huntington expression in patients with Huntington's disease in her interview with Dr. Jeffrey Ratliff. Read Dr. Tabrizi's paper in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMoa1900907?query=recirc_curatedRelated_article.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
July 16, 2019 Issue
SUDEP in the North American SUDEP Registry: The full spectrum of epilepsies
1. SUDEP in the North American SUDEP Registry: The full spectrum of epilepsies
2. [What's Trending]: Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
In the first segment, Dr. Halley Alexander talks with Dr. Orrin Devinsky about his paper on the full spectrum of epilepsies and the North American SUDEP Registry. In the second part of the podcast, Dr. Ted Burns focuses his discussion with Dr. Gil Wolfe on his Lancet Neurology paper on the long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis. You can read the paper here: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(18)30392-2/fulltext.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
July 9, 2019 Issue
Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease
1. Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease
2. [What's Trending]: The US Food and Drug Administration’s Authorization of the First Cannabis-Derived Pharmaceutical
In the first segment, Dr. Jeffrey Ratliff talks with Dr. Franziska Hopfner about her paper on the use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease. In the second part of the podcast, Dr. Jason Crowell focuses his discussion with Dr. Jerzy Szaflarski on his JAMA Neurology paper on the US Food and Drug Administration’s authorization of the first cannabis-derived pharmaceutical. You can read the paper here: https://jamanetwork.com/journals/jamaneurology/article-abstract/2714720.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
July 2, 2019 Issue
Current treatment practice of Guillain-Barré syndrome
1. Current treatment practice of Guillain-Barré syndrome
2. [What's Trending]: Somatic expansion of the C9orf72 Hexanucleotide Repeat does not occur in ALS spinal cord tissues (Neurology: Genetics)
In the first segment, Dr. Michelle Mauermann talks with Dr. Bart Jacobs about his paper on current treatment practice of Guillain-Barré syndrome. In the second part of the podcast, Dr. Matthew Harms focuses his discussion with Dr. Guy Rouleau on his Neurology: Genetics paper looking at how somatic expansion of the C9orf72 Hexanucleotide Repeat does not occur in ALS spinal cord tissues.
June 25, 2019 Issue
Interview with Neurology Editor-in-Chief Dr. Bob Gross, pt. 2
1. Interview with Neurology Editor-in-Chief Bob Gross, pt. 2
In the second part of a 2-part interview, Dr. Bob Gross changes to the journal and publishing as well as some controversies and challenges as Editor-in-Chief of Neurology.
June 18, 2019 Issue
Interview with Neurology Editor-in-Chief Bob Gross, pt. 1
1. Interview with Neurology Editor-in-Chief Bob Gross, pt. 1
In the first part of a 2-part interview, Dr. Bob Gross discusses his experiences, opportunities, and challenges as Editor-in-Chief of Neurology.
June 11, 2019 Issue
Lumbosacral Radiculoplexus Neuropathy: Incidence and the Association with Diabetes Mellitus
1. Lumbosacral Radiculoplexus Neuropathy: Incidence and the Association with Diabetes Mellitus
2. [What’s Trending]: CRGP monoclonal antibodies for migraine prevention
In the first segment, Dr. Stacey Clardy talks with Dr. P. James B. Dyck about his paper on the incidence of lumbrosacral radiculoplexus neuropathy and association with diabetes mellitus, from the March 12th issue. In the second segment, the interviewer talks with Dr. Teshamae Monteith about the use of CRGP monoclonal antibodies for migraine prevention.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
June 4, 2019 Issue
The Four Score as a predictor of outcome in adults with bacterial meningitis
1. The Four Score as a predictor of outcome in adults with bacterial meningitis
2. [What’s Trending]:Opioid prescribing and response to the CDC guidelines
In the first segment, the interviewer talks with Dr. C.N. van Ettekoven about the Four Score as a predictor of outcome in adults with bacterial meningitis, from the May 28th issue. In the second part of the podcast, Dr. Jason Crowell focuses his talk with Dr. Deborah Dowell on her NEJM perspective article looking at opioid prescribing and response to the CDC guidelines. You can read Dr. Dowell’s paper here: https://www.nejm.org/doi/full/10.1056/NEJMp1904190.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
May 28, 2019 Issue
Out-of-pocket costs are on the rise for commonly prescribed neurologic medications
1. Out-of-pocket Costs are on the Rise for Commonly Prescribed Neurologic Medications
2. [What’s Trending]: Diagnosing Genetic Ataxias
In the first segment, Dr. Jason Crowell talks with Dr. Brian Callaghan about the rising out-of-pocket costs for commonly prescribed neurologic medications. In the second part of the podcast, Dr. Jeffrey Ratliff focuses his interview with Dr. Stefan Pulst on diagnosing genetic ataxias.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
May 21, 2019 Issue
Long-term outcome in neuroZika: When biological diagnosis matters
1. Long-term outcome in neuroZika: When biological diagnosis matters
2. [What’s Trending]: Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors (NEJM)
In the first segment, Dr. Stacey Clardy talks with Dr. Annie Lannuzel about the importance of biological diagnosis in long-term outcome in neuroZika. In the second part of the podcast, Dr. Will Rondeau focuses his interview with Dr. Stuart Connolly on his NEJM paper on the full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. The paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa1814051.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
May 14, 2019 Issue
Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus
1. Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus
2. [What’s Trending]: Measles in 2019
In the first segment, Dr. Lindsay Higdon talks with Dr. Ivan Sanchez Fernandez about his paper on the meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus. In the second part of the podcast, Dr. Stacey Clardy talks with Dr. Anthony Fauci about the measles outbreak of 2019. You can read the paper in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMp1905099.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
May 7, 2019 Issue
Practice guideline recommendations summary: The treatment of tics in people with Tourette syndrome and chronic tic disorders
1. Practice guideline recommendations summary: The treatment of tics in people with Tourette syndrome and chronic tic disorders
2. [What’s Trending]: CRISPR and gene editing, pt. 2
In the first segment, Dr. Jeffrey Ratliff talks with Dr. Tamara Milka Pringsheim about her practice guideline recommendations summary paper on the treatment of tics in people with Tourette syndrome and chronic tic disorders. In the What's Trending segment, you'll hear the second part of an interview between Dr. Jason Crowell and New York Times staff writer Pam Belluck on CRISPR and gene editing.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
April 30, 2019 Issue
Mouse model of anti-NMDA receptor post–herpes simplex encephalitis (Neurology: Neuroimmunology & Neuroinflammation)
1. Neurology: Neuroimmunology & Neuroinflammation: Mouse model of anti-NMDA receptor post–herpes simplex encephalitis
2. [What's Trending]:Gene Editing
In the first segment, Dr. Stacey Clardy talks with Dr. Jenny Linnoila about her March 2019 Neurology: Neuroimmunology & Neuroinflammation paper on a mouse model of anti-NMDA receptor post–herpes simplex encephalitis. In the second part of the podcast, you will hear the first part of a 2-part interview about CRISPR and gene editing with New York Times staff writer Pam Belluck and Dr. Jason Crowell. You can read the NYT story here: https://www.nytimes.com/2019/04/14/health/gene-editing-babies.html?rref=collection%2Fbyline%2Fpam-belluck.
And, you will find the follow up here: https://www.nytimes.com/2019/04/16/health/stanford-gene-editing-babies.html?rref=collection%2Fbyline%2Fpam-belluck
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
April 23, 2019 Issue
Montreal Cognitive Assessment as a screening tool: Influence of performance and symptom validity
1. Neurology: Clinical Practice: Montreal Cognitive Assessment as a screening tool: Influence of performance and symptom validity
2. [What’s Trending]: Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
In the first segment, Dr. Gregory Day talks with Dr. Brigid Waldron-Perrine about her Neurology: Clinical Practice paper addressing the Montreal Cognitive Assessment as a screening tool. In the second part of the podcast, Dr. Jeffrey Burns focuses his interview with Dr. Mathias Jucker on how serum neurofilament dynamics predict neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease. The article can be found in Nature: https://www.nature.com/articles/s41591-018-0304-3.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
April 16, 2019 Issue
Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study
1. Comparative effectiveness of teriflunomide and dimethyl fumarate. A nationwide cohort study
2. [What’s Trending]: The Rise of Pseudomedicine for Dementia and Brain Health
In the first segment, Dr. Stacey Clardy talks with Dr. Mathias Buron about his paper addressing the comparative effectiveness of teriflunomide and dimethyl fumarate. In the second part of the podcast, Dr. Jason Crowell focuses his interview with Dr. Joanna Hellmuth on the rise of pseudomedicine for dementia and brain health.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
April 9, 2019 Issue
How much do periventricular lesions assist in distinguishing migraine with aura from CIS?
1. How much do periventricular lesions assist in distinguishing migraine with aura from CIS?
2. [What’s Trending]: Drug Pricing--Politico
In the first segment, Dr. Stacey Clardy talks with Dr. Caterina Lapucci about her paper addressing how much periventricular lesions assist in distinguishing migraine with aura from CIS. In the second part of the podcast, Dr. Jason Crowell focuses his interview with Sarah Karlin-Smith and Sarah Owermohle from Politico on drug pricing.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
April 2, 2019 Issue
Automated seizure detection accuracy for ambulatory EEG recordings
1. Automated seizure detection accuracy for ambulatory EEG recordings
2. [What’s Trending]: SHINE Stroke Trial
In the first segment, Dr. Derek Bauer talks with Dr. Stephan Schuele about his paper on automated seizure detection accuracy for ambulatory EEG recordings. In the second part of the podcast, Dr. Nicole Chiota-McCollum focuses her interview with Dr. Kevin Barrett on the SHINE stroke trial.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.